The current data showed a trend that CD34 positive cells might achieve clinical benefits in the treatment of patients with poststroke.
← all excerpts
Intrathecal Administration of Autologous CD34 Positive Cells in Patients with Past Cerebral Infarction: A Safety Study.
1
—
—